Splanchnic and renal exchange of infused fructose in insulin-deficient type 1 diabetic patients and healthy controls.

Fructose raises blood glucose and lactate levels in normal as well as diabetic man, but the tissue origin (liver and/or kidney) of these responses and the role of insulin in determining the end products of fructose metabolism have not been fully established. Splanchnic and renal substrate exchange was therefore examined during intravenous infusion of fructose or saline in six insulin-deficient type I diabetics who fasted overnight and in five healthy controls. Fructose infusion resulted in similar arterial concentrations and regional uptake of fructose in the two groups. Splanchnic glucose output increased threefold in the diabetics but remained unchanged in controls in response to fructose infusion, and the arterial glucose concentration rose more in diabetics (+5.5 mmol/liter) than in controls (+0.5 mmol/liter). Splanchnic uptake of both lactate and pyruvate increased twofold in response to fructose infusion in the diabetics. In contrast, a consistent splanchnic release of both lactate and pyruvate was seen during fructose infusion in controls. In diabetics fructose-induced hyperglycemia was associated with no net renal glucose exchange, while there was a significant renal glucose production during fructose infusion in the controls. In both groups fructose infusion resulted in renal output of lactate and pyruvate. In the diabetics this release corresponded to the augmented uptake by splanchnic tissues. In two diabetic patients given insulin infusion, all responses to fructose infusion were normalized. Fructose infusion in diabetics did not influence either splanchnic ketone body production or its relationship to splanchnic FFA inflow. We conclude that in insulin-deficient, mildly ketotic type I diabetes, (a) both the liver, by virtue of lactate, pyruvate, and fructose-derived gluconeogenesis, and the kidneys , by virtue of fructose-derived lactate and pyruvate production, contribute to fructose-induced hyperglycemia; (b) outcome of hepatic fructose metabolism; and (c) fructose does not exert an antiketogenic effect. These data suggest that while total fructose metabolism is not altered in diabetics, intermediary hepatic fructose metabolism is dependent on the presence of insulin.

[1]  A. Huggett,et al.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. , 1957, Lancet.

[2]  F. Heinz,et al.  Enzymes of fructose metabolism in human kidney. , 1975, Enzyme.

[3]  H. Mehnert,et al.  Antiketogenic Action of Fructose in Man , 1978, Diabetes.

[4]  W. Pritchard,et al.  Metabolism of Fructose by the Liver of Diabetic and Non-Diabetic Subjects.∗ , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[5]  P. Felig,et al.  Role of the Kidney in the Metabolism of Fructose in 60-hour Fasted Humans , 1982, Diabetes.

[6]  M. Mako,et al.  The metabolism of fructose in diabetes mellitus. , 1967, Journal of Laboratory and Clinical Medicine.

[7]  T. Van Itallie,et al.  Peripheral Assimilation of Fructose in Man.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  A. Mendeloff,et al.  Role of the human liver in the assimilation of intravenously administered fructose. , 1953, Metabolism: Clinical and Experimental.

[9]  E. Hultman,et al.  Liver and muscle glycogen in man after glucose and fructose infusion. , 1974, Scandinavian journal of clinical and laboratory investigation.

[10]  W. Drucker,et al.  The Metabolism of Fructose in Man §¶ , 1956, The Yale Journal of Biology and Medicine.

[11]  L. Rowell,et al.  INDOCYANINE GREEN CLEARANCE AND ESTIMATED HEPATIC BLOOD FLOW DURING MILD TO MAXIMAL EXERCISE IN UPRIGHT MAN. , 1964, The Journal of clinical investigation.

[12]  Georg Diehl Beiträge zur Pathologie und Therapie des Diabetes mellitus , 1875 .

[13]  S. Ahuja,et al.  Effects of intravenously administered fructose and glucose on splanchnic amino acid and carbohydrate metabolism in hypertriglyceridemic men. , 1975, The Journal of clinical investigation.

[14]  C. Brun A rapid method for the determination of para-aminohippuric acid in kidney function tests. , 1951, The Journal of laboratory and clinical medicine.

[15]  L. Hagenfeldt,et al.  A gas chromatographic method for the determination of individual free fatty acids in plasma. , 1966, Clinica chimica acta; international journal of clinical chemistry.

[16]  D. Seligson,et al.  A comparison of the metabolism of fructose and glucose in hepatic disease and diabetes mellitus. , 1953, The Journal of clinical investigation.

[17]  N. Tygstrup,et al.  THE MECHANISM OF THE FRUCTOSE EFFECT ON THE ETHANOL METABOLISM OF THE HUMAN LIVER. , 1965, The Journal of clinical investigation.

[18]  P. Hjemdahl,et al.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. , 1979, Life sciences.

[19]  Mendeloff Ai,et al.  Role of the human liver in the assimilation of intravenously administered fructose. , 1953 .

[20]  W. C. Elliott,et al.  Effects of rapid fructose infusion in man. , 1967, Journal of applied physiology.

[21]  E. Cerasi,et al.  Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. , 1972, The Journal of clinical investigation.

[22]  W. Meroney,et al.  Fructose in the treatment of diabetic ketosis. , 1953, The Journal of clinical investigation.